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served a nonsignificant increase in HIF-2  and HIF-3  mRNA 
expression in explants cultured at 1.5% oxygen. These data 
suggest that the mRNA expression of VEGF, and possibly HIF-
2  and HIF-3  , is regulated by hypoxia in the developing 
human lung.  Conclusion: This lung explant culture model 
appears to be a valuable model to unravel the molecular 
mechanisms of human lung development. 
 Copyright © 2009 S. Karger AG, Basel 
 Introduction 
 The molecular basis of pulmonary development has 
been studied extensively over the past few decades. Many 
morphogens, growth and transcription factors have been 
shown to play key roles during different stages of this pro-
cess  [1–3] . Accumulating evidence underlines the impor-
tance of vascular development in relation to distal airway 
growth and development  [4–6] . It is important to realize 
that normal prenatal (pulmonary) development occurs in 
a hypoxic environment. A number of studies have shown 
that hypoxia in utero is favorable for embryological or-
ganogenesis  [5, 7–9] .
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 Abstract 
 Background: Fetal lung development requires proper coor-
dination between lung epithelial and vascular morphogen-
esis. A major determinant in lung vascular development is 
vascular endothelial growth factor (VEGF), which is regulat-
ed by hypoxia-inducible factors (HIFs). VEGF is expressed in 
the airway epithelium, while its receptors (VEGFRs) are ex-
pressed in the pulmonary mesenchyme. The hypoxic envi-
ronment in utero is beneficial for fetal organogenesis, espe-
cially vascular development. However, little is known about 
the expression of HIFs and VEGFR-2 in the human fetal lung 
in vitro.  Objectives: The purpose of this study was to inves-
tigate the effects of hypoxia on fetal lung morphology and 
mRNA expression of VEGF, VEGFR-2, HIF-2  , and HIF-3  . 
 Methods: An explant culture technique was used to study 
the effects of normoxic and hypoxic conditions on human 
fetal lung.  Results: The morphology remained largely un-
changed in explants cultured under hypoxic or normoxic 
conditions. Quantitative RT-PCR showed that the mRNA ex-
pression of VEGF-A, but not VEGFR-2 is upregulated in ex-
plants cultured at 1.5% compared with 21% oxygen. We ob-
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 In mammalian systems, the cellular responses to oxy-
gen alteration are mediated by hypoxia-inducible factors 
(HIFs), which are known to control more than 100 genes 
 [10] . The HIF transcriptional complex is a heterodimer 
composed of one of the three oxygen-sensitive   subunits 
(HIF-1  , HIF-2  , or HIF-3  ) and the constitutive HIF-  
subunit, alternatively called aryl hydrocarbon receptor 
nuclear translocator (ARNT)  [11, 12] . Under hypoxic 
conditions, the HIF heterodimer is stable and accumu-
lates into the nucleus where it binds to hypoxia response 
elements of target genes, thereby regulating their tran-
scription. In normoxia, hydroxylation of the HIF-  sub-
unit by prolyl hydroxylases (PHDs) mediates an interac-
tion with the von Hippel-Lindau protein (pVHL), which 
subsequently leads to ubiquitination and targeting for 
proteasomal destruction  [11, 13] .
 One of the most potent hypoxia-inducible growth fac-
tors is vascular endothelial growth factor-A (VEGF-A). 
VEGF-A signals through two high-affinity tyrosine ki-
nase receptors, VEGF receptor (VEGFR)-1 (Flt-1), and 
VEGFR-2 (KDR in human or Flk-1 in mouse). In the lung, 
VEGF-A functions as a mitogen and differentiation fac-
tor for endothelial cells  [14] . While VEGF-A is expressed 
mainly in the epithelial cells of the lung  [15] , VEGFRs are 
expressed in the mesenchymal cells immediately under-
lying the epithelium and vascular structures  [16] . The 
level of VEGF is critical for normal lung development. 
Overexpression of VEGF in the distal lung airway epithe-
lium alters vascularization and arrests airway branching 
 [17] , whereas inhibition of VEGF results in less complex 
alveolar patterning and immature lung formation  [18] . 
Additionally, by using antisense oligonucleotides against 
HIF-1  and VEGF, our group previously demonstrated 
that epithelial branching morphogenesis is abolished 
when pulmonary vascular development is inhibited  [5] . 
The evidence that homozygous null VEGFR-2 mice die 
in utero as a result of a lack of mature endothelial cells 
and an absence of blood island formation, suggests a role 
of VEGFR-2 in mediating the mitogenic and chemotactic 
effect of VEGF-A on the endothelial cells  [19] .
 The variation of oxygen tension leads to a variable 
phenotype of lung development. In vitro studies using rat 
lung explants cultured at 3% oxygen showed an increase 
in epithelial branching and cellular proliferation, as com-
pared to explants cultured at 21% oxygen  [9] . Previous 
studies in transgenic mouse lungs showed an increase in 
both epithelial and endothelial branching morphogene-
sis in explants cultured at 3% oxygen compared with 21% 
oxygen  [5] .
 Based on the aforementioned information, a low-oxy-
gen environment of the fetus seems critical for pulmo-
nary angiogenesis and possibly airway branching mor-
phogenesis. Human lung explants maintained in vitro 
have been used in a number of studies on lung develop-
ment  [15, 20–27] . For instance, Acarregui et al.  [15] previ-
ously showed the effect of a low oxygen level and cAMP 
on the expression of VEGF mRNA. However, there are 
very little data available regarding the expression of HIF-
2  , HIF-3  and VEGFR-2 in the human fetal lung in vi-
tro. In this study, we used human fetal lung explants 
maintained in an in vitro culture system, to study the in-
fluence of low oxygen tension on the expression of HIF-
2  , HIF-3  , VEGF-A, and VEGFR2 in the developing 
human lung.
 Materials and Methods 
 Lung Tissue and Explant Culture 
 This study was approved by the Medical Ethical Committee of 
the Erasmus MC University Medical Center Rotterdam and by 
the board of directors of the Center for Anticonception, Sexuality 
and Abortion (CASA) in Leiden.
 Lung tissue was obtained from normal human fetuses after 
surgical termination of the pregnancy at 16, 17, 21, 22 and 22 
weeks of gestation and after obtaining informed consent. No 
medication was used to abort the pregnancy. The obtained tissue 
fragments were rinsed with PBS and lung tissue was identified 
macroscopically. The lung fragments were preserved in cooled 
(4 ° C) culture medium during transport. Within several hours, 
fetal lung tissue was carefully separated from the major blood ves-
sels and airways, and dissected into 1- to 2-mm 3 pieces. Lung ex-
plants (2–3 pieces) were placed separately on Nucleopore mem-
branes (pore size 8   m; Whatman, Den Bosch, The Netherlands), 
and cultured as air-liquid interface cultures in serum-free Way-
mouth’s MB752/1 medium (Gibco, Breda, The Netherlands) with 
1% penicillin-streptomycin and 1% insulin-transferrin-selenium 
(Gibco). The explants were maintained either under standard cul-
ture incubator conditions of 37 ° C and 5% CO 2 /95% air (21% oxy-
gen; normoxia), or in an incubator with 5% CO 2 , and 93.5% 
N 2 /1.5% O 2 (hypoxia). The culture medium was changed every 
24 h and the explant tissue was harvested after 3 or 6 days of cul-
ture.
 Immunohistochemistry 
 Immunohistochemistry was performed using the standard 
avidin-biotin complex method as previously published  [28] . In 
brief, subsequent to deparaffinization in xylene and rehydration 
through graded alcohol steps, slides were treated with 3% H 2 O 2 
in methanol to block the endogenous peroxidase activity. For an-
tigen retrieval, slides were subjected to microwave treatment in 
citric acid buffer, pH 6.0 (Ki-67, TTF-1) or pronase (CD-31). After 
the blocking step, slides were incubated for 30 min at room tem-
perature with a primary antibody against Ki-67 (1: 150, Dako, 
Heverlee, Belgium), TTF-1 (1: 100, Ab-1, Neomarkers, Calif., 
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USA), or CD-31 (1: 30, clone MIB-1, Dako). After rinsing with 
PBS, slides were incubated for 10 min with a biotinylated second-
ary antibody (Labvision, Calif., USA), followed by incubation 
with peroxidase-conjugated streptavidin (Labvision). Peroxidase 
activity was detected by diaminobenzidine tetrahydrochloride 
(Fluka, Buchs, Switzerland) in 0.3% H 2 O 2 and counterstained 
with hematoxylin. Negative controls were performed by omission 
of the primary antibodies.
 RNA Isolation and Quantitative RT-PCR 
 Uncultured lung tissue and explants cultured for 3 and 6 days 
were used for quantitative PCR analysis. Total RNA was isolated 
using Trizol reagent according to the manufacturer’s instructions 
(Invitrogen, Breda, The Netherlands). RNA was quantified by 
measuring the absorbance at 260 nm and the purity was checked 
by the 260/280-nm absorbance ratio. Total RNA (1   g) was added 
to a reaction mixture containing 50 m M Tris-HCl (pH 8.3), 75 m M 
KCl, 3 m M MgCl 2 , 10 m M dithiothreitol, 100 ng random hexamer 
primer, 500   M of each deoxynucleotide triphosphate (dATP, 
dGTP, dCTP and dTTP), 10 U RNAse inhibitor and 200 U Mo-
loney murine leukemia virus reverse transcriptase (all reagents 
were obtained from Invitrogen). The RT thermal cycle was 1 h at 
37 ° C followed by incubation for 15 min at 99 ° C (for primers see 
 table 1 ).
 Real-time PCR was performed using an iCycler IQ Real time 
PCR detection system (Bio-Rad, Veenendaal, The Netherlands) 
and qPCR Core kit for SYBR Green I (Eurogentech, Seraing, Bel-
gium) with the following conditions: 10 min of initial denatur-
ation at 95 ° C followed by 40 cycles of 95 ° C for 30 s, 58 ° C for
30 s, 60 ° C for 30 s, and 75 ° C for 15 s. The sequences for the gene-
specific primers used in this study can be found in  table 1 . To 
verify the specificity of the amplified products, each PCR was fol-
lowed by a melting curve analysis from 55 to 95 ° C. Each sample 
was run in triplicate and mRNA of each target gene was deter-
mined simultaneously in a 96-well plate. Negative (no enzyme) 
and no-template (no cDNA) controls were also included. RNA 
polymerase II subunit A (POLR2A) was used as an internal refer-
ence for the relative quantitation of the PCR signals. The fold 
change was calculated as 2 –   Ct according to Livak and Schmitt-
gen  [29] . Lung tissue from day 0 (starting material) was used as a 
control group (arbitrary value = 1).
 Statistical Analysis 
 Data from the quantitative PCR are presented as mean 2 –   Ct 
 8 SEM. The differences between the experimental groups were 
evaluated using one-way ANOVA with post hoc least significant 
difference test. A p value of  ! 0.05 was considered statistically sig-
nificant. All statistics were calculated using SPSS statistical pack-
age (version 11.0; SPSS Inc., Chicago, Ill., USA).
 Results 
 Morphology of Human Fetal Lung Explants Cultured 
at 21% Oxygen 
 To evaluate the feasibility of fetal lung explant culture 
in vitro under our conditions, human fetal lung explants 
derived from mid-trimester abortions were maintained 
at 21% oxygen for 6 days. Macroscopically, the explants 
appeared vital until at least 6 days of culture. The micro-
scopic appearance of mid-trimester explants after cul-
turing for 3 and 6 days resembled the pseudoglandular 
stage of lung development; except that the airways were 
dilated and the epithelial cells appeared flattened ( fig. 1 ). 
To evaluate cell differentiation characteristics of the ex-
plants, sections of explants cultured for 3 and 6 days were 
immunostained with markers for epithelial cells (TTF-
1), endothelial cells (CD-31) and proliferation (Ki-67). 
There was no difference in the expression pattern of all 
markers between uncultured lungs and explants cul-
tured for 3 or 6 days at 21% oxygen. Virtually all epithe-
lial cells were positive for TTF-1 staining ( fig. 2 a, d, g), 
while endothelial cells were positive for CD-31 ( fig. 2 b,
e, h). Ki-67 immunoreactivity was observed in both epi-
thelial and mesenchymal cells ( fig. 2 c, f, i). Double 
immunohistochem ical staining with Ki-67 and CD-31 
showed ongoing endothelial proliferation in the explants 
cultured under normoxic conditions after 6 days in cul-
ture ( fig. 3 b).
 Morphologic Changes Associated with Exposure to 
Hypoxia 
 Sections of the explants were immunostained with Ki-
67, TTF-1 and CD-31 after culture for 6 days at either 
normoxic or hypoxic conditions. Uncultured tissue from 
Table 1. Primer sequences for quantitative PCR
Gene Forward primer (5]3) Reverse primer (5]3)
HIF2- CCA ATC CAG CAC CCA TCC CAC GTT GTA GAT GAC CGT CCC CTG
HIF3- ACC TGG AAG GTG CTG AAC TG AAT CCT GTC GTC ACA GTA GG
VEGF-A AGA ATC ATC ACG AAG TGG TG TGT TGT GCT GTA GGA AGC TC
VEGFR-2 CAG AGT GGC AGT GAG CAA AG TAC ACG ACT CCA TGT TGG TC
POLR2A CGG ATG AAC TGA AGC GAA TG AGC AGA AGA AGC AGA CAC AG
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the same patient was used as a control. The airways were 
larger in both hypoxic and normoxic cultured lungs at 
day 6 as compared to control tissue. There was no differ-
ence in the localization of TTF-1 ( fig. 2 g, j) and CD-31 
( fig. 2 h, k) between explants cultured at 21 and 1.5% oxy-
gen. However, CD-31 immunoreactivity appeared to be 
stronger in hypoxia-exposed lungs as compared to ex-
plants cultured at normoxia ( fig. 2 k vs. h). A proliferation 
marker, Ki-67, was expressed in both epithelial and mes-
enchymal cells in control tissue and explants cultured at 
21% oxygen ( fig. 2 c, f, i) but appeared to be more restrict-
ed to the epithelium in explants cultured at 1.5% oxygen 
( fig. 2 l). 
 Quantitative RT-PCR 
 Quantitative RT-PCR showed that VEGF-A, VEGFR-
2, HIF-2  , and HIF-3  mRNA were expressed in all ex-
perimental groups. Relative mRNA expression of each 
gene was demonstrated as mean  8 SEM in  figure 4 (n = 
5/group). There was an increase in VEGF-A mRNA ex-
pression in explants cultured at 1.5% oxygen compared 
with explants cultured at 21% oxygen and control (p  ^  
0.01). However, under hypoxic conditions, VEGF-A 
mRNA expression was downregulated in explants cul-
tured for 6 days compared with 3 days (p  ! 0.01). There 
was no significant change in the expression of the other 
investigated genes between the explants cultured in nor-
moxia and hypoxia, although the expression of HIF-2  
appeared higher in the explants cultured at 1.5% oxygen 
at day 3 compared with explants cultured at 21% oxygen 
without reaching statistical significance.
 Discussion 
 The developing lung requires the formation and main-
tenance of a vascular network in close proximity to a lay-
er of alveolar epithelial cells. In this study, we demon-
strated that human lung explants cultured for 3–6 days 
at 1.5% oxygen maintain appropriate proliferation and 
differentiation of the airway epithelium as well as vas-
cularization. Moreover, we demonstrated that VEGF-A 
mRNA expression was increased in the explants cultured 
under hypoxic conditions. In line with the increased ex-
pression of VEGF-A, we found that both HIF-2  and 
HIF-3  were slightly elevated in the hypoxic cultures, al-
a b c
d e f
 Fig. 1. Representative images showing the morphology of human fetal lung explants (gestational age 16 weeks) 
cultured at 21% oxygen. Macroscopic pictures of uncultured fetal lung explants ( a ) and after culture for 3 ( b ) 
and 6 days ( c ). Hematoxylin-eosin staining of uncultured lung ( d ) resembles the pseudoglandular stage of lung 
development. The airways are dilated after culture for 3 ( e ) and 6 days ( f ) at 21% oxygen. Bar = 100   m. 
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 Fig. 2. Immunohistochemical staining with TTF-1, CD-31, and 
Ki-67 of uncultured lung ( a–c ), explants cultured at 21% for 3 
( d–f ) or 6 days ( g–i ), and 1.5% oxygen for 6 days ( j–l ). TTF-1 im-
munoreactivity is detected in epithelial cells ( a ,  d ,  g ,  j ). Explants 
cultured at 1.5% oxygen ( k ) show stronger CD-31 staining of en-
dothelial cells compared with control ( b ) and explants cultured at 
21% oxygen ( e ,  h ). Ki-67 staining ( c ,  f ,  i ,  l ) shows proliferating 
epithelial cells and mesenchymal cells in control ( c ) and explants 
kept at 21% oxygen ( f ,  i ), while the expression is more restricted
to the epithelium in explants kept at 1.5% oxygen ( l ). Bar = 
500   m. 
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though the differences with normoxic cultures were not 
statistically significant.
 Fetal lung explants maintained in vitro are a well-
characterized model for studying fetal lung development. 
The differentiation of mid-gestational human fetal lung 
explants in culture has been characterized both biochem-
ically and morphologically in several studies  [15, 20–22, 
24–27, 30] , as depicted in  table 2 . However, there is little 
information on the role of hypoxia at the cellular level in 
human fetal lung development. Previous studies in mu-
rine lungs have shown that hypoxia enhances the devel-
opment of pulmonary vasculature and airway epithelial 
branching morphogenesis, as compared to ambient oxy-
gen  [5, 9] .
 In the present study, the airway epithelium of the ex-
plants appeared flattened within a dilated airspace after 
being maintained at 1.5% oxygen for 6 days. There was 
no obvious difference in the localization of epithelium- 
(TTF-1) and endothelium- (CD31) specific markers be-
tween human lung explants cultured at 1.5 or 21% oxy-
gen. Immunostaining with the proliferation marker Ki-
67 showed that cells in the lung explants were still 
dividing. A formal quantification of cell proliferation was 
not performed, due to the small number of samples. 
These findings indicate that the cultured lung tissue 
maintains its normal structure and growth capacity.
 The close anatomical relationship between airways 
and blood vessels in the lung suggests their putative in-
Table 2. Previous studies with human fetal lung explants
Point of interest Culture condition Main results Ref.
Morphological change
Cell differentiation 20% O2 Spontaneous differentiation of airway epithelium into type II
pneumocytes
20
Apoptosis 20% O2 d Number of cell undergoing apoptosis especially in the interstitium 25
In response to hyperoxia 95 vs. 20% O2 f Number of vessels and VEGF mRNA expression in hyperoxia
f Cell proliferation in the interstitium but not in epithelium
27
Surfactant protein
Effects of O2 70 or 95 vs. 20% d SP-A, SP-C mRNA, SP-B unchanged 24, 30
Effects of retinoic acid 8 retinoic acid f SP-A, SP-C mRNA, d SP-B mRNA 22
Effects of glucocorticoids 8 dexamethasone d SP-A mRNA at lower concentration but f at concentration >10–8 M 21
VEGF pathway
Effects of O2, cAMP 2 vs. 20% O2
8 cAMP
d VEGF mRNA and protein after 2–4 days in 2% O2
cAMP d VEGF mRNA in 20% but not 2% 
15
Effect of exogenous VEGF 8 recombinant 
VEGF
VEGFR-2 expressed in distal airway epithelium
Exogenous VEGF d epithelium volume density, tissue differentiation and
d SP-A, SP-C mRNA, SP-B unchanged
26
a b
 Fig. 3. Double immunostaining of Ki-67 
and CD-31 on explants cultured at 21% ox-
ygen for 6 days. Ki-67 immunoreactivity is 
detected in epithelium and mesenchyme 
( a ). Double staining with CD-31 (pink in 
the online version) shows proliferating en-
dothelial cells (arrows;  b ). Bar = 250   m. 
C
o
lo
r v
er
si
o
n 
av
ai
la
b
le
 o
n
lin
e
 Rajatapiti /de Rooij /Beurskens /Keijzer /
Tibboel /Rottier /de Krijger 
Neonatology 2010;97:346–354 352
teraction during development. The inhibition of vascu-
larization in mouse lungs in vitro results in a decrease in 
epithelial branching morphogenesis  [5, 31] . VEGF has 
been shown to act as a potent inducer of endothelial cell 
growth and hypoxia is one of its most important stimu-
li  [14, 15] . VEGF is essential for embryonic development, 
as it was shown that inactivation of a single VEGF allele 
results in embryonic lethality with impaired vessel for-
mation  [14, 32] . In this study, we have shown that VEGF-
A mRNA expression is significantly upregulated in lung 
explants cultured at 1.5% oxygen, as compared to nor-
moxic conditions. Similar findings have been reported 
for VEGF expression in human  [15] , mouse  [5] , and rat 
 [9] fetal lung explants cultured at low oxygen. However, 
these studies have not established the relationship with 
expression of HIFs and VEGF. Our results confirm that 
low oxygen stimulates VEGF expression and probably 
vascular development in human fetal lung develop-
ment.
 The expression of VEGFR-2 is stimulated by HIF-2  
 [33] , but there are no reports of an oxygen-dependent up-
regulation of VEGFR-2 expression in human lung. Previ-
ous studies in lung explants of a transgenic mouse model 
have shown that VEGFR-2 mRNA expression was sig-
nificantly increased after 2 days in culture under hypox-
ic conditions. However, with extension of the culture 
 period, this difference was no longer noticeable  [5] . Our 
results also showed no significant difference in the ex-
pression of VEGFR-2 mRNA between 1.5 and 21% oxy-
gen after 3 or 6 days in culture. Apparently, factors other 
than hypoxia are also important in the expression of 
VEGF receptors in human pulmonary mesenchyme. It is 
possible that the expression of VEGFR-2 is oxygen-de-
pendent, but the effect of oxygen was already diminished 
when we studied the cultured tissue at day 3.
 VEGF gene transcription is activated by hypoxia 
through HIF-1  and HIF-2   [34–36] . These two factors 
have a close sequence similarity, but their modes of ex-
2
4
6
8
10
12
d0 Nd3 Hd3 Nd6 Hd6
VEGF-A
*
#*
1
d0 Nd3 Hd3 Nd6 Hd6
VEGFR-2
2
3
0
0
0.5
1.0
1.5
2.0
d0 Nd3 Hd3 Nd6 Hd6
HIF-2
0.5
Control Nd3 Hd3 Nd6 Hd6
HIF-3
1.0
1.5
0
R
e
la
ti
v
e
m
R
N
A
e
x
p
re
ss
io
n
 Fig. 4. Relative mRNA expression of 
VEGF-A, VEGFR-2, HIF-2  , and HIF-3  
in human fetal lung explants maintained 
for 3 or 6 days in 21% O 2 (Nd3 and Nd6, 
respectively) or 1.5% O 2 (Hd3 and Hd6, re-
spectively) and uncultured lungs (d0). For 
relative quantification, the expression of 
POLR2A mRNA was used as reference 
gene. Bars represent means  8 SEM (n = 5). 
The expression of VEGF-A mRNA is up-
regulated in explants cultured at 1.5% oxy-
gen (Hd3 and Hd6) as compared to ex-
plants cultured at 21% oxygen (Nd3 and 
Nd6) and control (d0), but its expression in 
explants kept at hypoxic conditions is de-
creased when cultured for a longer period 
(Hd6 vs. Hd3).  * p  ^  0.01 vs. d0, Nd3, and 
Nd6;  # p  ! 0.01 vs. Hd3. 
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pression vary greatly, and HIF-1  and HIF-2  have 
unique targets  [10] . HIF-1  is ubiquitously expressed in 
the developing embryo  [37] and in the lung, where it is 
detected in the branching epithelium of the first-trimes-
ter lung but also in some mesenchymal cells  [16] . HIF-1  
double-knockout mice die in utero at e10.5 with cardiac, 
vascular defects and extensive cell death  [38, 39] . HIF-2  
is abundantly expressed in murine adult lungs under nor-
moxic conditions  [34, 40] , especially in the developing 
mesenchyme and vasculature  [37] . HIF-2  -null mice die 
in the embryonic stage with abnormal lung maturation 
and blood vessel defects  [41] , and a defect in catechol-
amine production  [35] . However, a subset of HIF-2  
knockout offspring survives postnatally but suffers from 
respiratory distress due to surfactant deficiency  [42] . An-
other member of the HIF family, HIF-3  , appears to be 
involved in negative regulation of the angiogenic re-
sponse through an alternative splice variant, inhibitory 
PAS domain protein (IPAS)  [43] . IPAS can be induced by 
hypoxia in the heart and lung resulting in a negative feed-
back loop for HIF-1  activity in these tissues  [44] . A pre-
vious study in adult mice by Heidbreder et al.  [40] report-
ed that mRNA expression of HIF-3  , but not HIF-2  in-
creased significantly corresponding to the duration of 
systemic hypoxia. In addition, they found an increase in 
both HIF-2  and HIF-3  protein levels  [40] . In the A549 
cell line, HIF-1  and HIF-3  showed a different response 
to hypoxia (1% O 2 ), which led to the suggestion that HIF-
3  is complementary rather than redundant to HIF-1  
induction  [45] . Our analysis with quantitative PCR 
showed only a slight increase in HIF-2  and HIF-3  
mRNA expression in explants cultured under hypoxic 
conditions at day 3, but this difference was not signifi-
cant. However, it must be noted that the regulation of 
HIF-  factors is mainly post-transcriptional, and there-
fore this could very well explain the marginal differences 
between the hypoxic and normoxic cultures  [13] . So, 
aside from the presence of both HIF-2  and HIF-3  , we 
showed that the expression of their main target, VEGF-A, 
is significantly upregulated upon hypoxia. This indicates 
that although the expression of both factors is only slight-
ly elevated, the transcriptional activity of the HIF factors 
is increased under hypoxic conditions. At this point, we 
cannot discriminate whether HIF-2  or HIF-3  is the 
main inducer of VEGF.
 In summary, this study has demonstrated that fetal 
human lung explants exposed to hypoxia (1.5% oxygen) 
maintain proper epithelial and mesenchymal morpho-
genesis. An increase in VEGF-A expression under hy-
poxic conditions suggests its role in regulating pulmo-
nary vascular and airway development. Human fetal lung 
explants maintained in a serum-free system allowed us to 
focus on the local effects of oxygen tension rather than a 
systemic response to hypoxia. Moreover, the establish-
ment of this model of normal human fetal lung develop-
ment might also open up the possibility of studying ab-
normal lung development such as pulmonary hypoplasia 
resulting from obstructive uropathy and oligohydram-
nios, or in case of congenital diaphragmatic hernia. A 
better understanding of the abnormal processes in these 
conditions will enhance our knowledge of the pathogen-
esis of pulmonary defects. In addition, this model can be 
applied to investigate the effect of different ligands or 
medications that have an effect on lung development 
such as retinoic acid and steroid hormone. This may pro-
vide us with new therapeutic interventions, both pre- and 
postnatally.
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